All ProductsDisplaying Products by Catalog Number (7500 - 7599)
010002000300040005000600070008000900100011001200130014001500160017001800190020002100220023002400250026002700280029003000310032003300340035003600370038003900400041004200430044004500460047004800490050005100520053005400550056005700580059006000610062006300640065006600670068006900700071007200730074007500760077007800
| Cat. No. | Product Name / Activity |
|---|---|
| 7503 | MD13 |
| Potent MIF Degrader (PROTAC®) | |
| 7504 | MD15 |
| Negative control for MD13 (Cat. No. 7503) | |
| 7505 | PLpro inhibitor 19 New |
| SARS-CoV-2 PLpro and replication inhibitor | |
| 7506 | Click N-Acetylmuramic acid - azide |
| Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
| 7507 | Evofosfamide |
| Hypoxia-activated DNA alkylating agent prodrug | |
| 7508 | EMD 527040 hydrochloride |
| ανβ6 integrin inhibitor | |
| 7509 | NR12S |
| Fluorogenic lipid membrane dye | |
| 7510 | Indocyanine green |
| Near-infrared fluorescent dye | |
| 7512 | 3-Bromopyruvate |
| MCT1 inhibitor; also inhibits hexokinase II | |
| 7513 | Lenalidomide 4'-PEG1-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7514 | Lenalidomide 4'-PEG2-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7515 | Lenalidomide 4'-PEG3-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7516 | Lenalidomide 4'-alkylC3-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7517 | Lenalidomide 4'-alkylC5-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7518 | Thalidomide 4'-ether-PEG1-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7519 | Thalidomide 4'-ether-PEG2-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7520 | Thalidomide 4'-ether-PEG3-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7521 | Thalidomide 4'-ether-alkylC3-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7522 | Thalidomide 4'-ether-alkylC5-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7523 | TSA Vivid™ Fluorophore Kit 520 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 7525 | dCeMM2 New |
| Molecular glue Degrader; induces ubiquitination and degradation of cyclin K | |
| 7526 | TSA Vivid™ Fluorophore Kit 570 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 7527 | TSA Vivid™ Fluorophore Kit 650 |
| Signal amplification kit for use in ISH, ICC and IHC | |
| 7528 | BSJ-4-116 |
| Selective CDK12 PROTAC® Degrader | |
| 7529 | BSJ-4-116-NC |
| Negative control for BSJ-4-116 (Cat. No. 7528). | |
| 7530 | dTAG-47 |
| Degrades mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation | |
| 7531 | dTAG-47-NEG |
| Negative control for dTAG-47 (Cat. No. 7530) | |
| 7532 | CSN5i-3-NEG |
| Negative control for CSN5i-3 (Cat. No. 7089) | |
| 7533 | ZE 132 New |
| Potent and selective PD-1/PD-L1 interaction inhibitor | |
| 7538 | NBD-PE |
| Fluorescent label for lysosomal lipid bodies | |
| 7541 | Helianorphin-19 |
| Opioid receptor (KOR) agonist | |
| 7542 | SJ 1008066 |
| MAGE-A11 inhibitor disrupts MAGE-A11:PCF11 interaction | |
| 7546 | C28 New |
| Potent LMTK3 inhibitor | |
| 7549 | BAY 1816032 |
| Potent and selective BUB1 kinase inhibitor | |
| 7551 | NCT 02 |
| Molecular glue; induces degradation of CCNK and CDK12 | |
| 7553 | Ac4ManNDAz |
| Photo-crosslinking probe for studying glycoproteins and glycolipids | |
| 7554 | SSYA10-001 |
| Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6 | |
| 7557 | Thalidomide 5'-amine-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7558 | SRT 1720 |
| Selective SIRT1 activator; induces autophagy and mitochondrial biogenesis | |
| 7563 | Tissue Clearing Pro Reagent 1 |
| Tissue clearing reagent | |
| 7564 | Tissue Clearing Pro Reagent 2 |
| Tissue clearing reagent | |
| 7565 | Tissue Clearing Pro-Organoid Reagent |
| 3D cell culture clearing reagent | |
| 7566 | VH 032 amide-alkylC9-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 7568 | VH 032 amide-PEG6-amine |
| VHL ligand with PEG linker and terminal amine for onward chemistry | |
| 7569 | Verdinexor New |
| Selective exportin-1 (XPO1/CRM1) inhibitor | |
| 7573 | BAY 1797 New |
| Selective P2X4 antagonist | |
| 7575 | aTAG 2139-NEG |
| Negative control for aTAG 2139 (Cat. no. 6970) | |
| 7577 | 3-Mercaptopicolinic acid hydrochloride New |
| Phospoenolpyruvate carboxykinase (PEPCK) inhibitor; inhibits gluconeogenesis | |
| 7578 | Tocriscreen Epigenetics 3.0 |
| A library of 160 epigenetic compounds (100 μL, 10 mM DMSO solutions) for high throughput screening, high content screening and chemical biology applications | |
| 7579 | Olaparib |
| Potent PARP inhibitor | |
| 7580 | WIC1 |
| Inhibitor of Wnt/β-catenin signaling | |
| 7583 | SK 575 |
| Potent PARP1 Degrader (PROTAC®) | |
| 7584 | iP300v |
| Negative control for iP300w (Cat. No. 7270) | |
| 7586 | Molnupiravir |
| Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection | |
| 7588 | SK 575-NEG |
| Negative control for SK 575 (Cat. No. 7583) | |
| 7589 | Adavosertib |
| Potent and selective Wee1 inhibitor | |
| 7590 | Pexidartinib |
| Potent CSF-1R inhibitor | |
| 7591 | CB 839 |
| Potent glutaminase GLS1 inhibitor |